7676 - 7700 of 7939 Results
Title
Year
-
OPENTitle: Genetic variability at the PARK16 locusJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 12Start Page: 1356End Page: 1359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ejhg.2010.125Best OA location URL: https://www.nature.com/articles/ejhg2010125.pdfCitation Count: 89
- Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases2010RESTRICTEDTitle: Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesJournal Name: Journal of NeurochemistryPublisher: WileyVol: 114Issue #: 5Start Page: 1261End Page: 1276Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06834.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2010.06834.xCitation Count: 30
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors2010OPENTitle: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 1490End Page: 1495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2010.114Best OA location URL: http://www.cell.com/article/S1525001616310991/pdfCitation Count: 76
- Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations2010OPENTitle: Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutationsJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1791End Page: 1800Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23221Best OA location URL: https://europepmc.org/articles/pmc6005705?pdf=renderCitation Count: 237
-
OPENTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Best OA location URL: https://europepmc.org/articles/pmc2939165?pdf=renderCitation Count: 12
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Best OA location URL: https://europepmc.org/articles/pmc2939261?pdf=renderCitation Count: 40
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice2010OPENTitle: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 3Start Page: 503End Page: 517Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.07.010Best OA location URL: https://europepmc.org/articles/pmc2955774?pdf=renderCitation Count: 259
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization2010OPENTitle: 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localizationJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 430Issue #: 3Start Page: 393End Page: 404Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1042/bj20100483Best OA location URL: https://portlandpress.com/biochemj/article-pdf/430/3/393/878058/bj4300393.pdfCitation Count: 373
- Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neurons2010RESTRICTEDTitle: Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neuronsJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 45Issue #: 4Start Page: 324End Page: 334Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2010.07.004Citation Count: 21
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010OPENTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 388
- Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective N-Methyl-d-aspartate Receptor Antagonists2010OPENTitle: Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective N-Methyl-d-aspartate Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 15Start Page: 5476End Page: 5490Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm100027pBest OA location URL: https://europepmc.org/articles/pmc2920070?pdf=renderCitation Count: 84
- Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations2010OPENTitle: Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutationsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 33Issue #: 4Start Page: 814End Page: 823Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.05.009Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2010.05.009Citation Count: 205
- Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)2010OPENTitle: Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 20Issue #: 17Start Page: 5175End Page: 5178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2010.07.007Best OA location URL: https://europepmc.org/articles/pmc2922490?pdf=renderCitation Count: 26
- Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia2010OPENTitle: Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementiaJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 225Issue #: 1Start Page: 210End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.06.017Best OA location URL: https://europepmc.org/articles/pmc2922478?pdf=renderCitation Count: 182
-
OPENTitle: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 480Issue #: 1Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009Best OA location URL: https://europepmc.org/articles/pmc2943649?pdf=renderCitation Count: 193
- Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)2010OPENTitle: Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)Journal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 11Start Page: 1530End Page: 1537Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23151Best OA location URL: https://europepmc.org/articles/pmc4775095?pdf=renderCitation Count: 24
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
- Low‐dose bafilomycin attenuates neuronal cell death associated with autophagy‐lysosome pathway dysfunction2010OPENTitle: Low‐dose bafilomycin attenuates neuronal cell death associated with autophagy‐lysosome pathway dysfunctionJournal Name: Journal of NeurochemistryPublisher: WileyVol: 114Issue #: 4Start Page: 1193End Page: 1204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06838.xBest OA location URL: https://europepmc.org/articles/pmc2910188?pdf=renderCitation Count: 71
-
OPENTitle: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevinJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 10Start Page: 695End Page: 699Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3bBest OA location URL: https://europepmc.org/articles/pmc2889226?pdf=renderCitation Count: 14
-
OPENTitle: Risk of sleep-disordered breathing in Parkinson's diseaseJournal Name: Sleep and BreathingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 3Start Page: 471End Page: 478Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11325-010-0362-3Best OA location URL: https://europepmc.org/articles/pmc2978748?pdf=renderCitation Count: 42
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice2010OPENTitle: Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged miceJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 107Issue #: 21Start Page: 9879End Page: 9884Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1004676107Best OA location URL: https://europepmc.org/articles/pmc2906862?pdf=renderCitation Count: 475
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys2010RESTRICTEDTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Citation Count: 149
-
RESTRICTEDTitle: Prevention strategies for herpes zoster and post-herpetic neuralgiaJournal Name: Journal of Clinical VirologyPublisher: Elsevier BVVol: 48Issue #:Start Page: S14End Page: S19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1386-6532(10)70004-4Best OA location URL: https://europepmc.org/articles/pmc5391038?pdf=renderCitation Count: 32
- Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease2010OPENTitle: Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3000664Best OA location URL: https://europepmc.org/articles/pmc2933751?pdf=renderCitation Count: 135
-
OPENTitle: Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasmJournal Name: Protein Engineering, Design and SelectionPublisher: Oxford University Press (OUP)Vol: 23Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/protein/gzq022Best OA location URL: https://academic.oup.com/peds/article-pdf/23/6/489/17494272/gzq022.pdfCitation Count: 57